In recent years, the FDA has begun approving GLP-1s specifically for chronic weight management to help treat obesity, as they can increase satiety, decrease hunger and result in significant weight loss
Tirzepatide: a Novel, once-weekly dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes
A systematic review and meta-analysis published in the British Journal of Clinical Pharmacology (Rhim et al., 2019) examined multiple trials of L-arginine supplementation
If Saxenda isnt included in your BCBS plans formulary, you can ask your healthcare provider to submit an exception request, or you could appeal the denial
The most common side effects of Ozempic in adults include nausea, diarrhea, vomiting, stomach (abdominal) pain, and constipation
The use of GLP-1 medications such as Ozempic and Wegovy for weight loss has been increasing